Global Non animal Type Hard Capsules Market Size By Type (Type I, 00E), By Application (Pharmaceutical, Nutraceutical), By Region, And Segment Forecasts, 2023 to 2032

The Global Non-Animal Type Hard Capsules Market was valued at USD 710 million in 2023 and is projected to surpass USD 1.32 billion by 2031, growing at a CAGR of 8.2% during the forecast period from 2023 to 2031. This growth is fueled by the increasing shift toward plant-based and vegan products, rising consumer preference for clean-label supplements, and regulatory support for non-animal-derived pharmaceutical excipients. Non-animal hard capsules, commonly made from hydroxypropyl methylcellulose (HPMC) and pullulan, are gaining rapid traction in pharmaceuticals, nutraceuticals, and dietary supplement applications globally.

Drivers:

1. Rise in Vegan and Vegetarian Populations:

A growing global shift toward plant-based lifestyles is increasing demand for animal-free alternatives in dietary supplements and medications, boosting the adoption of non-animal hard capsules.

2. Clean-Label and Allergen-Free Trends:

Consumers are increasingly seeking allergen-free, GMO-free, and clean-label products. Non-animal hard capsules cater to these preferences as they are free from gelatin and animal derivatives.

3. Pharmaceutical Industry Adoption:

Pharmaceutical manufacturers are turning to non-animal capsules due to religious, dietary, and ethical constraints, particularly in regions like the Middle East, India, and Southeast Asia.

Restraints:

1. Higher Production Costs:

Compared to traditional gelatin capsules, non-animal alternatives are often more expensive to produce due to specialized raw materials and processing methods.

2. Limited Availability in Developing Regions:

In less mature pharmaceutical and nutraceutical markets, access to non-animal hard capsules remains limited due to cost concerns and lower awareness.

Opportunity:

1. Expansion of Nutraceutical Industry:

With the rise of self-care and preventive health, the nutraceutical sector presents a significant opportunity for non-animal capsule manufacturers to introduce innovative products.

2. Technological Advancements in Capsule Manufacturing:

Improvements in capsule shell formulation, including moisture resistance and compatibility with hygroscopic fills, are enhancing the performance of non-animal capsules, opening new application areas.

Market by System Type Insights:

Based on system type, HPMC Capsules dominated the market in 2023, attributed to their stability, suitability for a wide range of fill materials, and regulatory approval across global markets. HPMC capsules are widely adopted in both pharmaceutical and nutraceutical products. However, Pullulan Capsules are gaining traction due to their natural origin, enhanced oxygen barrier properties, and appeal among clean-label brands.

Market by End-use Insights:

The Nutraceuticals segment held the largest revenue share in 2023, driven by growing consumer preference for herbal and plant-based supplements. The Pharmaceuticals segment is projected to grow at the fastest rate, supported by increasing demand for animal-free and Halal/Kosher certified medication delivery systems.

Market by Regional Insights:

North America led the market in 2023, owing to widespread vegan trends, high awareness, and significant demand in the dietary supplement industry. Asia-Pacific is expected to experience the fastest growth through 2031, fueled by the rise in contract manufacturing, regional pharmaceutical growth, and shifting cultural dynamics favoring plant-based solutions.

Competitive Scenario:

Key players operating in the Global Non-Animal Type Hard Capsules Market include:

Capsugel (Lonza Group)

ACG Worldwide

Qualicaps

HealthCaps India Ltd.

Sunil Healthcare Ltd.

Roxlor LLC

Natural Capsules Ltd.

Suheung Co., Ltd.

These companies are focusing on sustainable production methods, expansion into high-growth markets, and innovations in capsule shell materials and customization.

Scope of Work – Global Non-Animal Type Hard Capsules Market

Report Metric Details

Market Size (2023) USD 710 million

Projected Market Size (2031) USD 1.32 billion

CAGR (2023–2031) 8.2%

Market Segments By System Type (HPMC, Pullulan), End-use (Pharmaceuticals, Nutraceuticals), Region

Growth Drivers Rising vegan trend, clean-label demand, pharma industry uptake

Opportunities Nutraceutical expansion, tech innovation in capsule production

Key Market Developments:

2023: Lonza Group expanded its Capsugel® Vcaps® Plus portfolio with improved oxygen barrier properties for sensitive nutraceutical formulations.

2024: ACG announced a strategic partnership with a major Southeast Asian pharmaceutical company to supply plant-based capsule shells.

2025: HealthCaps launched a new line of organic-certified HPMC capsules targeting herbal supplement brands in Europe and North America.

FAQs:

1. What is the current market size of the Global Non-Animal Type Hard Capsules Market?

The market was valued at USD 710 million in 2023.

2. What is the major growth driver of the Global Non-Animal Type Hard Capsules Market?

The key growth driver is the rising global demand for plant-based and allergen-free health products.

3. Which is the largest region during the forecast period in the Global Non-Animal Type Hard Capsules Market?

North America held the largest market share in 2023, while Asia-Pacific is projected to witness the fastest growth.

4. Which segment accounted for the largest market share in Global Non-Animal Type Hard Capsules Market?

The Nutraceuticals segment led the market in 2023.

5. Who are the key market players in the Global Non-Animal Type Hard Capsules Market?

Major players include Lonza Group, ACG Worldwide, Qualicaps, HealthCaps India Ltd., and Natural Capsules Ltd.